tablets "Dekaris" are applied at the following indications:
- ascaridosis;
- necatoriasis;
- ankilostomidoz.
Structure
Active ingredient - levamisole (one tablet contains levamisole 50 mg (in the form of 59 mg of levamisole of a hydrochloride)).
Excipients: starch corn, sodium saccharin, povidone, talc, aroma apricot, magnesium stearate, yellow decline of FCF (E 110).
Contraindication
Hypersensitivity to levamisole or to any excipient which is a part of medicine.
Route of administration
byto Children medicament is appointed in the form of tablets on 50 mg once (evening) in a dose of 2.5 mg/kg of body weight:
- 3-6 years (body weight - 10-20 kg) - 25-50 mg (1/2-1 tablet);
- 7-10 years (body weight - 20-30 kg) - 50-75 mg (1-1.5 tablets);
- 11-18 years (body weight - 30-60 kg) - 75-100 mg (1.5-3 tablets).
Tablet to children according to purpose and under observation of the doctor. >
it is reasonable to p to take the Drug with a small amount of water after meal of evening.
does not haveIn use of depletive or a special diet need.
In case of need treatment is repeated after a 7-14-day break.
Feature of use
Pregnant women
In a research on animals did not observe teratogenic action. Well controlled researches with the assistance of pregnant women were not conducted therefore during pregnancy it is only possible to appoint the medicament "Dekaris" if the expected advantage exceeds possible risk of use of drug.
Does not know towhether levamisole gets into breast milk of the woman, however it was defined in cow's milk. For prevention of negative impact on the baby it is necessary to resolve an issue of need of administration of medicament for the woman who nurses.
Reproductive researches on animals did not show toinfluence on fertility.
toDrivers
byit is not proved that levamisole affects ability to drive the car or other mechanisms though it was reported about encephalopathy as very rare side reaction at treatment by levamisole.
byOverdose
At reception of a high dose of levamisole (over 600 mg) described such symptoms of intoxication: nausea, vomiting, lethargy, spasms, diarrhea, headache, dizziness and confusion of consciousness. At the doses exceeding recommended it was reported about convulsion.
Treatment: at accidental overdose if after reception there passed a little time, it is necessary to wash out a stomach. Monitoring of vital indicators and performing symptomatic therapy is necessary. In case of presence of signs of antikholinesterazny action it is possible to enter atropine as antidote.
Side effects
from a cardiovascular system: heart consciousness.
from the system of blood and lymphatic system: agranulocytosis, leukopenia.
Mental disorders: insomnia.
from the central nervous system: spasms, dizziness, encephalopathy, headache.
from digestive tract: abdominal pain, diarrhea, nausea, vomiting.
from the immune system: reactions of hypersensitivity, including rash, an itching and a Quincke's disease.
Storage conditionsto Store
at a temperature not above 25 °C, out of children's reach.
Expiration date - 5 years.
Characteristics | |
Active ingredients | Levamisole |
Amount of active ingredient | 50 mg |
Applicant | Gideon Richter |
Code of automatic telephone exchange | P02CE01 Levamisole |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | blister |
Producer | GIDEON RICHTER OF JOINT STOCK COMPANY |
Quantity in packing | 2 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 15 °C to 30 °C |
Trade name | Decarice |
Decarice of the tab. of 50 mg No. 2
- Product Code: 182934
- In Stock
- Ready to ship
-
$23.41